Ownership Summary
Baird Medical Investment Holdings Ltd (NASDAQ:BDMD) showed up in the 13F filings of 8 institutional investors as of December 2025.
- These investors held 2.0% of outstanding shares in December 2025, up from 1.7% in September 2025.
- Their total shares held in BDMD increased 36.43% quarter over quarter, and separately, investors owning Baird Medical Investment Holdings increased 14.29% from a year ago.
- Of these 8 holders, 3 added to their stakes in Baird Medical Investment Holdings, 1 trimmed positions, and 4 made no changes.
- Combined, these investors held 529.36K shares in BDMD for December 2025, up by 141.36K shares quarter on quarter, and up 223.86K shares year over year.
- As of December 31, 2025, the biggest holder of Baird Medical Investment Holdings is HIGHBRIDGE CAPITAL MANAGEMENT LLC at 125.0K shares, representing 0.47% of shares outstanding.
- Leading buyers of Baird Medical Investment Holdings shares for the quarter ending December 2025 were TWO SIGMA INVESTMENTS, LP (95.44K), CITADEL ADVISORS LLC (66.13K), NATIONAL BANK OF CANADA /FI/ (11.7K).
- The biggest sellers of Baird Medical Investment Holdings for the quarter ending December 2025 included UBS Group AG (31.91K).
- Business Quant data shows the 8 biggest positions in Baird Medical Investment Holdings as of December 2025 are held by HIGHBRIDGE CAPITAL MANAGEMENT LLC (125.0K), PERISCOPE CAPITAL INC. (125.0K), CITADEL ADVISORS LLC (112.66K), TWO SIGMA INVESTMENTS, LP (95.44K), UBS Group AG (33.91K), GEODE CAPITAL MANAGEMENT, LLC (25.44K), NATIONAL BANK OF CANADA /FI/ (11.7K), WOLVERINE ASSET MANAGEMENT LLC (205).